三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
FGFR2基因的三种不同突变类型:融合,点突
FGFR2基因的三种不同突变类型:融合,点突
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:844KB
图片尺寸:1143*1077
同报告图片
/
4
PHxiZWdpbl9vZl9ib3h8PnwgRkdGUjLnqoHlj5gv5pS55Y+Y57G75Z6LICAgICAgIHwg576O5Zu95bm05Y+R55eF5Lq65pWwICAgICAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IEZ1c2lvbu+8iOiejeWQiO+8iSAgICAgICAgICAgfCB+NC41SyAtIDE0SyAgICAgICAgICAgIHwKfCBNdXRhdGlvbu+8iOeCueeqgeWPmO+8iSAgICAgICB8IH42LjVLIC0gMjFLICAgICAgICAgICAgfAp8IFRvdGFsIEZHRlIyIGFsdGVyYXRpb25zICB8IH4xMSAtIDM1SyBwYXRpZW50cyAgICAgfAoK6LWE5paZ5p2l5rqQ77ya6Ieq54S26IK/55ik5a2m57u86L+w5p2C5b+XMjAxNzx8ZW5kX29mX2JveHw+
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
fCDpobnnm64gICAgICAgICAgICAgICAgfCDkuK3lm70gICAgICAgICAgfCDnvo7lm70gICAgICAgICAgfCDkuK3nvo7lkIjorqEgICAgICAgIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tfAp8IOW5tOWPkeeXheeOhyAgICAgICAgICAgIHwgfjYwLDAwMCAgICAgICB8IH4xNCwwMDAgICAgICAgfCDigJQgICAgICAgICAgICAgICB8Cnwg5ZWG5Lia5r2c5Yqb77yIVVMk77yJICAgICB8IH5VUyQ2NTBtICAgICAgfCB+VVMkODUwbSAgICAgIHwgflVTJDEuNWJuICAgICAgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOi1hOaWmQ==
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
所属报告:
和誉(2256.HK)-港股公司首次覆盖:中国小分子新药研发标兵迎接商业化转型元年-251002(44页).pdf
打包全文图表
相关数据
anti-FGFR2b单抗与SOS1抑制剂国内临床进展
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
收藏
行业数据
2025-12-31
原图定位
查看详情
美国FGFR2基因突变在不同实体瘤的发病人数
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
收藏
行业数据
2025-10-10
原图定位
查看详情
和誉FGFR2/3抑制剂将针对胃癌和软骨发育不全症两个适应症展开
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
收藏
行业数据
2025-10-10
原图定位
查看详情
全球在研的FGFR2b单抗产品
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
收藏
行业数据
2025-09-24
原图定位
查看详情
全球在研FGFR2bADC
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
收藏
行业数据
2025-07-07
原图定位
查看详情
FGFR2靶向药物研究进展及竞争格局
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
收藏
竞争格局
2024-05-17
原图定位
查看详情
中国主要FGFR1/2/3畸变癌症新发病例
fCDlubTku70gfCDkubPohbrnmYzvvIjljYPkvovvvIkgfCDog4PnmYzvvIjljYPkvovvvIkgfCDog4bnrqHnmYzvvIjljYPkvovvvIkgfCDlsL/ot6/kuIrnmq7nmYzvvIjljYPkvovvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18CnwgMjAxNiB8IDU0ICAgICAgICAgICAgIHwgMjggICAgICAgICAgIHwgMjYgICAgICAgICAgICAgfCAyMiAgICAgICAgICAgICAgIHwKfCAyMDIwIHwgNTggICAgICAgICAgICAgfCAzMSAgICAgICAgICAgfCAyOSAgICAgICAgICAgICB8IDI0ICAgICAgICAgICAgICAgfAp8IDIwMjVFfCA2MiAgICAgICAgICAgICB8IDM3ICAgICAgICAgICB8IDM0ICAgICAgICAgICAgIHwgMjkgICAgICAgICAgICAgICB8CnwgMjAzMEV8IDY1ICAgICAgICAgICAgIHwgNDIgICAgICAgICAgIHwgNDAgICAgICAgICAgICAgfCAzNCAgICAgICAgICAgICAgIHwKfCAyMDM1RXwgNjcgICAgICAgICAgICAgfCA0NiAgICAgICAgICAgfCA0NSAgICAgICAgICAgICB8IDM4ICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaRnJvc3QgJiBTdWxsaXZhbuOAgea1pumTtuWbvemZhQ==
收藏
行业数据
2022-08-02
原图定位
查看详情
中国主要FGFR1/2/3畸变癌症新发病例
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
收藏
行业数据
2022-08-01
原图定位
查看详情
国内处于临床阶段的泛FGFR抑制剂和FGFR1/2/3抑制剂
<table border="1" cellspacing="0" cellpadding="5">
    <thead>
        <tr style="background-color: #004080; color: white;">
            <th>药物名称</th>
            <th>公司名称</th>
            <th>适应症</th>
            <th>临床阶段</th>
            <th>首次公示日期</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td rowspan="3">Pemigatinib</td>
            <td rowspan="3">信达</td>
            <td>一线胆管癌</td>
            <td>递交上市申请</td>
            <td>2021/7/2</td>
        </tr>
        <tr>
            <td>二线胆管癌</td>
            <td>二期</td>
            <td>2019/12/27</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2019/12/23</td>
        </tr>
        <tr>
            <td rowspan="5">Erdafitinib</td>
            <td rowspan="5">强生</td>
            <td>二线尿路上皮癌</td>
            <td>三期</td>
            <td>2018/11/27</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>二期</td>
            <td>2017/7/5</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>二期</td>
            <td>2020/3/23</td>
        </tr>
        <tr>
            <td>非肌层浸润性膀胱肿瘤</td>
            <td>二期</td>
            <td>2020/9/15</td>
        </tr>
        <tr>
            <td>二线晚期肝细胞癌</td>
            <td>I/II期</td>
            <td>2017/7/25</td>
        </tr>
        <tr>
            <td rowspan="2">Infigratinib</td>
            <td rowspan="2">Alcami</td>
            <td>胆管癌</td>
            <td>三期</td>
            <td>2021/2/18</td>
        </tr>
        <tr>
            <td>胃癌或胃食管结合部腺癌</td>
            <td>二期</td>
            <td>2021/2/25</td>
        </tr>
        <tr>
            <td rowspan="3">HMPL - 453</td>
            <td rowspan="3">和黄医药</td>
            <td>晚期恶性复治间皮瘤</td>
            <td>二期</td>
            <td>2019/11/4</td>
        </tr>
        <tr>
            <td>晚期肝内胆管癌</td>
            <td>二期</td>
            <td>2020/5/22</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>I/II期</td>
            <td>2017/7/28</td>
        </tr>
        <tr>
            <td rowspan="2">ICP - 192</td>
            <td rowspan="2">诺诚健华</td>
            <td>尿路上皮癌</td>
            <td>二期</td>
            <td>2020/4/27</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>I/II期</td>
            <td>2018/11/22</td>
        </tr>
        <tr>
            <td>E7090</td>
            <td>卫材</td>
            <td>胆管癌</td>
            <td>二期</td>
            <td>2020/8/14</td>
        </tr>
        <tr>
            <td>Derazantinib</td>
            <td>仑胜医药</td>
            <td>胆管癌</td>
            <td>I/II期</td>
            <td>2019/5/27</td>
        </tr>
        <tr>
            <td rowspan="4">AL 8326</td>
            <td rowspan="4">爱德程医药</td>
            <td>小细胞肺癌</td>
            <td>I/II期</td>
            <td>2020/9/11</td>
        </tr>
        <tr>
            <td>妇科恶性肿瘤</td>
            <td>一期</td>
            <td>2021/1/18</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2018/12/12</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2017/2/3</td>
        </tr>
        <tr>
            <td rowspan="3">MAX 40279</td>
            <td rowspan="3">再极医药</td>
            <td>MDS，复发或难治性 AML</td>
            <td>I/II期</td>
            <td>2021/6/2</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2019/12/26</td>
        </tr>
        <tr>
            <td>复发难治性 AML</td>
            <td>一期</td>
            <td>2019/10/9</td>
        </tr>
        <tr>
            <td>BGJ398</td>
            <td>诺华</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2014/9/11</td>
        </tr>
        <tr>
            <td>EOC317</td>
            <td>亿腾景昂</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2018/4/9</td>
        </tr>
        <tr>
            <td>HH185</td>
            <td>上海海和、思路迪</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2018/10/23</td>
        </tr>
        <tr>
            <td>SYHA1803</td>
            <td>石药</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2019/6/28</td>
        </tr>
        <tr>
            <td>SC0011</td>
            <td>智康弘仁</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2021/2/18</td>
        </tr>
        <tr>
            <td>BPI - 17509</td>
            <td>贝达药业</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2019/10/23</td>
        </tr>
        <tr>
            <td rowspan="2">AL58805</td>
            <td rowspan="2">爱德程医药</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2021/4/15</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2019/1/14</td>
        </tr>
        <tr>
            <td>AZD 4547</td>
            <td>和誉生物</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2021/4/23</td>
        </tr>
        <tr>
            <td>HZB1006</td>
            <td>哈尔滨珍宝</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2021/5/25</td>
        </tr>
    </tbody>
</table>

<p>资料来源：丁香园，申万宏源研究</p>
收藏
行业数据
2021-08-18
原图定位
查看详情
所有目前已知的FGFR1、2、3、4突变率
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
收藏
行业数据
2021-07-20
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
ABSK121是一种高度选择性、强效的第二代小分子FGFR抑制剂,其最大特点是能够克服多种FGFR耐药突变。专门针对原发性FGFR2及FGFR3突变以及那些预测会导致对当前FGFR靶向疗法产生获得性耐药性的突变。这包括在胆管癌、膀胱癌及其他类型癌症中观察到的门控开关、分子刹车及激活环突变。
行业数据
原图定位
当前图表所属:
和誉(2256.HK)-港股公司首次覆盖:中国小分子新药研发标兵迎接商业化转型元年-251002(44页).pdf
全球三款CSF-1R抑制剂在国际多中心注册性临床开发的速度对比
TGCT腱鞘巨细胞瘤的治疗
腱鞘巨细胞瘤临床举例以及中美流行病学大致情况
和誉截至2025年9月的临床管线示意
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》